β-Hydroxybutyrate脱酶 1:对于各种疾病来说是一个有前途的治疗标
Xiaotong Ma1, Ze Wang1, Haoyang Gao1
1Shanghai Key Lab of Human Performance, Shanghai University of Sport, Shanghai 200438, China.
Biochemical pharmacology
|June 25, 2025
概括
β-基酸脱酶1 (BDH1) 对于代谢至关重要,并影响葡萄糖调节,炎症和亡. 研究突出了BDH1的研究成果.
科学领域:
- 生物化学 生物化学
- 代谢途径 代谢途径
- 线粒体功能 线粒体功能
背景情况:
- β-Hydroxybutyrate脱酶1 (BDH1) 是一种内线粒体膜酶,对体代谢至关重要.
- 新兴研究表明,BDH1参与了更广泛的生理和病理过程,包括葡萄糖平衡,氧化应激,炎症和亡.
研究的目的:
- 审查BDH1在各种疾病中的多方面的作用.
- 探索饮食和药理干预对BDH1表达的影响.
- 评估BDH1作为潜在的治疗点,特别是在代谢障碍方面.
主要方法:
- 对BDH1.1现有研究的文献综述.
- 对BDH1参与代谢障碍,癌症和心肌病的研究进行分析.
- 对调查饮食和药物对BDH1的影响的研究进行审查1.
主要成果:
- 除了基本代谢之外,BDH1在各种病理状况中发挥着重要作用.
- 饮食和药物剂可以调节BDH1的表达.
- 人们越来越认识到BDH1在疾病机制中的参与.
结论:
- BDH1与一系列疾病有关,包括代谢障碍,癌症和心肌病.
- 了解BDH1在疾病中的机制对于开发治疗策略至关重要.
- BDH1是一个有前途的治疗点,特别是在代谢疾病中.
更多相关视频
11:44Cellular Membrane Affinity Chromatography Columns to Identify Specialized Plant Metabolites Interacting with Immobilized Tropomyosin Kinase Receptor B
Published on: January 19, 2022
2.6K
05:55Identifying Inhibitors of the HBx-DDB1 Interaction Using a Split Luciferase Assay System
Published on: December 21, 2019
6.9K
相关概念视频
Drug Biotransformation: Overview
3.0K
Pharmaceutical substances known as xenobiotics are predominantly lipophilic and nonionized. This enables them to permeate lipid bilayers, such as cell membranes, and interact with intracellular target receptors. Lipophilic drugs have an advantage in crossing biological barriers and reaching their intended sites of action. However, lipophilic drugs often have a restricted capacity for renal expulsion or elimination from the body. When these drugs enter the kidneys and undergo glomerular...
3.0K
Targets for Drug Action: Overview
7.5K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
7.5K
